关于参与竞拍喀斯玛控股有限公司股权的进展公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、交易基本情况 证券代码：688179 证券简称：阿拉丁 公告编号：2025-054 转债代码：118006 转债简称：阿拉转债 上海阿拉丁生化科技股份有限公司 三、本次交易对公司的影响 本次交易旨在拓宽公司产品的销售渠道，提高产品开发能力，整合上下游资 源，提升公司的市场竞争力和盈利能力，有利于公司和投资者利益。 四、风险提示 公司将根据有关部门意见有序推进后续交易，并及时履行信息披露义务，持 续披露后续进展情况。敬请广大投资者理性投资，注意投资风险。 特此公告。 上海阿拉丁生化科技股份有限公司 董事会 二十四次会议，审议通过了《关于参与竞拍中国科学院控股有限公司持有的喀斯 玛控股有限公司 81.96%的股权的议案》，同意公司参与中科院控股所持标的股份 的竞拍。本次交易不构成关联交易，亦不构成《上市公司重大资产重组管理办法》 规定的重大资产重组。根据《上海证券交易所科创板股票上市规则》及《公司章 程》等相关规定，本次竞拍属于董事 ...

Core Points - The company, Shanghai Aladdin Biochemical Technology Co., Ltd., has maintained its credit rating for both the company and its convertible bonds at "A+" with a stable outlook [1][4] - The tracking credit rating was conducted by Zhongzheng Pengyuan Credit Rating Co., Ltd. and the results were published on June 24, 2025 [1][2] - The previous credit rating for the company and its bonds was also "A+" with a stable outlook, indicating consistency in the company's financial health [1][4] Summary by Sections - **Company Credit Rating**: The company's main credit rating remains "A+" with a stable outlook, reflecting its solid financial position [1][4] - **Bond Credit Rating**: The credit rating for the "Aladdin Convertible Bonds" is also maintained at "A+" with a stable outlook, indicating reliability for investors [1][4] - **Rating Agency**: The credit rating was performed by Zhongzheng Pengyuan, which conducted a comprehensive analysis of the company's operational status and related industry [1][4]

Core Viewpoint - The company, Shanghai Aladdin Biochemical Technology Co., Ltd., is set to hold an investor briefing on June 30, 2025, to discuss its 2024 annual report and Q1 2025 results, allowing investors to engage and ask questions [2][3][4]. Group 1: Meeting Details - The investor briefing will take place on June 30, 2025, from 09:00 to 10:00 [5]. - The location for the meeting is the Shanghai Stock Exchange Roadshow Center, accessible online [5]. - The meeting will be conducted in an interactive online format, enabling real-time communication with investors [3][5]. Group 2: Participation Information - Investors can submit questions from June 23 to June 27, 2025, via the Roadshow Center website or through the company's email [2][4]. - The company will address commonly asked questions during the briefing [3][4]. - Key personnel participating in the meeting include the Chairman and General Manager, Xu Jiuzhen, and the Secretary of the Board, Zhao Xin'an [4]. Group 3: Contact Information - For inquiries, investors can contact the Securities Affairs Department at 021-50560989 or via email at aladdindmb@163.com [6]. - After the briefing, the main content and outcomes will be available on the Roadshow Center website [6].

Core Points - The annual general meeting of Shanghai Aladdin Biochemical Technology Co., Ltd. was held on May 15, 2025, with no rejected proposals [2] - All resolutions presented at the meeting were approved, including the annual reports and profit distribution plans [4][5][6] Meeting Details - The meeting took place at the company's office in Shanghai, with a combination of on-site and online voting methods [2] - The chairman, Mr. Xu Jiuzhen, presided over the meeting, ensuring compliance with relevant laws and regulations [2][3] Attendance - Out of 9 current directors, 7 attended the meeting, while all 3 supervisors were present [3] - The board secretary and all senior executives were also in attendance [3] Resolutions Passed - Key resolutions included the approval of the 2024 Board of Directors' work report, the 2024 Supervisory Board's work report, and the 2024 annual financial report [4][5] - The proposal for the 2025 financial budget and the reappointment of the auditing firm for 2025 were also approved [5][6] Legal Verification - The meeting was witnessed by lawyers from Shanghai Jintiancheng Law Firm, confirming that all procedures and resolutions were in accordance with the law [7] Management Appointment - On May 15, 2025, the board appointed Mr. Tan Xiaoyong as the vice president, effective immediately [8][9] - Mr. Tan holds 1,791,395 shares in the company and meets all qualifications for the position [10]

Core Viewpoint - Shanghai Aladdin Biochemical Technology Co., Ltd. has appointed Mr. Tan Xiaoyong as the Vice General Manager, effective from May 15, 2025, until the end of the current board term [1]. Group 1: Appointment Details - The appointment was approved during the 39th meeting of the fourth board of directors [1]. - Mr. Tan Xiaoyong holds 1,791,395 shares in the company and meets the qualifications required by relevant laws and regulations [2]. Group 2: Mr. Tan Xiaoyong's Background - Mr. Tan Xiaoyong, born in October 1984, is a Chinese national with a master's degree [4]. - His previous roles include positions in marketing and business development at various companies, and he has been involved in financial management and executive roles since 2020 [4].

根据对企业的营商环境调研发现，传播涉企侵权信息、知识产权侵害、牟利性职业索赔是很多企业遇到 的共性问题。 根据世界银行近日公布的2025年度中国企业调查报告，上海有22项营商环境测评点达到了全球最优水 平。这是上海近年来开足马力持续优化营商环境的结果，也是新的起点。 在5月8日举行的新闻发布会上，上海市政府副秘书长、市发展改革委主任顾军表示，今年2月5日，上海 市连续第八年召开优化营商环境大会，发布了《上海市聚焦提升企业感受 持续打造国际一流营商环境 的行动方案》，即8.0方案，聚焦提升企业感受，安排了58条任务举措。目前，上海各相关部门和各区 陆续发布优化营商环境的专项方案，统一工作步调，形成矩阵式整体推进的良好态势，取得初步成果。 与此同时，上海市发展改革委印发《关于加力提速推进2025年优化营商环境"十大攻坚突破任务"的通 知》，选取企业需求迫切、部门协同推进要求高的十个事项进行攻坚突破，加力推出增量举措，攻坚解 决裉节问题，公开接受社会监督。通过重点协调、重点推进、重点督查、重点宣介，推动各项任务尽早 落地，确保年内取得明显成效。 十大攻坚突破任务均为"老大难" "营商环境好不好，企业说了算。"上海市 ...

Group 1 - The company, Shanghai Aladdin Biochemical Technology Co., Ltd., issued a total of 3.874 million convertible bonds, raising a total of RMB 387.4 million, with a net amount of RMB 373.38 million after deducting issuance costs [2][3] - The bonds have a maturity of six years, with an annual interest rate that increases from 0.4% in the first year to 3.0% in the sixth year [3][4] - The initial conversion price for the bonds is set at RMB 63.72 per share, which can be adjusted based on specific corporate actions [5][13] Group 2 - The company has provisions for adjusting the conversion price in case of stock dividends, capital increases, or other corporate actions that affect share capital [6][8] - If the stock price falls below 85% of the conversion price for 15 out of 30 consecutive trading days, the company can propose a downward adjustment of the conversion price, subject to shareholder approval [9][17] - The company has successfully adjusted the conversion price multiple times, with the latest adjustment setting it at RMB 16.17 per share effective from March 26, 2025 [14][18] Group 3 - The company has a credit rating of A+ for the convertible bonds, indicating a stable outlook [12] - The bonds are listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board, providing liquidity and visibility to investors [3][5] - The company is committed to maintaining investor rights and will closely monitor the bond's principal and interest repayment situation [18]